Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
AUTOR(ES)
Roh, Mark S.
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2773471Documentos Relacionados
- Fludarabine plus cyclophosphamide prolongs disease-free survival in CLL
- Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
- Time-Varying Effects of Prognostic Factors Associated With Disease-Free Survival in Breast Cancer
- Young age: an independent risk factor for disease-free survival in women with operable breast cancer
- Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial